Patent certification options
Brand vs first ANDA filer Activity Summary
NDA Patent and Data Exclusivity
Multiple ANDAs http://www.fda.gov/CDER/GUIDANCE/5710fnl.pdf
skip to main |
skip to sidebar
GMP, DMF, active pharmaceutical ingredients (APIs), ドラッグマスターファイル,原薬 原料藥, generic drug, 學名藥, 仿制藥, biogeneric drug
This Blog
Tag
- regulation (36)
- Business (33)
- Japan (28)
- Taiwan (19)
- 日法規 (15)
- Asia (8)
- patent (7)
- biogenerics (6)
- Blog Notice (5)
- Europe (5)
Archive
Visitors
沒有留言:
張貼留言